Report of Foreign Issuer (6-k)
October 20 2016 - 5:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the Month of October 2016
Commission File Number 001-33042
Rosetta Genomics Ltd.
(Translation of registrant’s name into English)
10 Plaut Street, Science Park
Rehovot 76706, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Rosetta Genomics Ltd.
On October 20, 2016, Rosetta Genomics Ltd. (the “Company”)
issued a press release announcing the appointment of Mark R. Willig as Chief Commercial Officer. A copy of the press release is
filed as Exhibit 99.1 to this Form 6-K and incorporated by reference herein.
The information contained in this Report (including the exhibit
hereto) is hereby incorporated by reference into the Company’s Registration Statements on Form F-3, File Nos. 333-163063,
333-171203, 333-172655, 333-177670, 333-185338, 333-207697 and 333-210366.
Exhibits
Exhibit
Number
|
|
Description of Exhibit
|
|
|
|
99.1
|
|
Press Release dated October 20, 2016.
|
|
|
|
Signatures
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
ROSETTA GENOMICS LTD.
|
|
|
|
|
Date: October 20, 2016
|
By:
|
/s/ Ron Kalfus
|
|
|
Ron Kalfus
Chief Financial Officer
|
Rosetta Genomics (CE) (USOTC:ROSGQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Rosetta Genomics (CE) (USOTC:ROSGQ)
Historical Stock Chart
From Sep 2023 to Sep 2024